EP3274266A1 - Verschlusskappe für ein behältnis zum aufnehmen einer medizinischen flüssigkeit - Google Patents
Verschlusskappe für ein behältnis zum aufnehmen einer medizinischen flüssigkeitInfo
- Publication number
- EP3274266A1 EP3274266A1 EP16712842.0A EP16712842A EP3274266A1 EP 3274266 A1 EP3274266 A1 EP 3274266A1 EP 16712842 A EP16712842 A EP 16712842A EP 3274266 A1 EP3274266 A1 EP 3274266A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sealing
- sealing element
- cap
- closure cap
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000007789 sealing Methods 0.000 title claims abstract description 243
- 239000007788 liquid Substances 0.000 title abstract description 13
- 239000012530 fluid Substances 0.000 claims description 27
- 239000003978 infusion fluid Substances 0.000 claims description 2
- 238000002347 injection Methods 0.000 description 19
- 239000007924 injection Substances 0.000 description 19
- 238000001802 infusion Methods 0.000 description 12
- 230000000249 desinfective effect Effects 0.000 description 7
- 230000002093 peripheral effect Effects 0.000 description 7
- 239000004033 plastic Substances 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000002788 crimping Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1406—Septums, pierceable membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1431—Permanent type, e.g. welded or glued
Definitions
- Cap for a container for receiving a medical
- the invention relates to a closure cap for a container for receiving a medical fluid according to the preamble of claim 1.
- Such a closure cap comprises a cap body which delimits an interior space and has at least one opening. At least one connecting device is arranged on the cap body, to which a conveying device for feeding a medical fluid into the container or for removing a medical fluid from the container can be connected.
- the connection device has a sealing element arranged on the cap body, which is arranged for sealing closure at the opening.
- a conveyor for connecting the conveyor can be attached.
- Such a conveying device can be designed, for example, as an injection syringe, which can be attached to the sealing element with an injection cannula and introduced into a fitting direction in the sealing element, so that the sealing element is pierced by the injection cannula.
- Such a syringe is used in particular for supplying a medical fluid into the container.
- an infusion set may be used, for example, which is attached to the sealing element with a spike, which is also referred to as a spike, so that the sealing element is pierced by the spike and thus creates access to the receptacle becomes.
- connection devices each having a sealing element are provided.
- One of these connection devices is used for supplying a medical fluid into a container connected to the closure cap, for example a bottle, while the other connection device serves for removing a medical fluid from the container.
- connection devices of which a first for supplying a medical fluid by means of a syringe, a second for removing a medical fluid by means of a mandrel having infusion set and a third to provide a so-called needle-free access is used.
- the sealing element of the third connection device has a slot opening, which makes it possible to attach a conveying device, for example a syringe, with a needle-free connecting piece to the sealing element in order to open the sealing element and to supply a liquid to the container in this way.
- Legal requirements may make it necessary to wipe or blot the sealing element on its outside before applying a conveying device, for example a hypodermic syringe for supplying a medical fluid or an infusion set for taking out a medical fluid, for disinfecting.
- a conveying device for example a hypodermic syringe for supplying a medical fluid or an infusion set for taking out a medical fluid, for disinfecting.
- the object of the present invention is to provide a closure cap in which the disinfection of a sealing element arranged thereon is simplified. This object is achieved by an article having the features of claim 1.
- the cap according to the invention closes an access to a container. For example, the cap closes the opening in the neck of a bottle.
- the sealing element is convex on its outer side.
- the sealing element protrudes with its outer side towards an upper side of the cap body to the outside.
- the sealing element is formed convex on its outer side, it can be ensured that after wiping or dabbing no disinfecting liquid remains on the sealing element, but can be removed in a reliable, simple manner by wiping or blotting. If the sealing element protrudes outwards with respect to an upper side of the cap body, then the sealing element can be easily accessed by brushing along the upper side with a suitable disinfecting tool, for example a swab or a wipe, in order in this way dab or wipe the sealing element on its outside.
- a suitable disinfecting tool for example a swab or a wipe
- the outside of the sealing element corresponds to the side of the sealing element which is visible from the outside and to which a conveying device, for example an injection syringe or an infusion set or another conveying device, can be attached.
- the outside is thus accessible from the outside, to connect a conveyor to the cap.
- the sealing element has a central thickness of 2 mm to 8 mm and / or an overall diameter of 4 mm to 14 mm.
- the outside is advantageously part of a sealing head of the sealing element, which extends through the opening.
- the sealing element lies with its sealing head in the opening and closes in this way the opening, wherein the outer side formed on the sealing head faces outward and thus faces away from the interior of the closure cap.
- the sealing head has a diameter of 2 mm to 10 mm.
- the central region of the sealing head for providing the convex outer side has a thickness greater by 0.1 to 1 mm than the edge region of the sealing head.
- a center of the convex outside of the sealing member is 0.1 to 1 mm, preferably 0.3 mm to 0.7 mm, above an outer upper edge of a sealing head of the sealing element.
- a break-off piece is preferably connected to the cap body such that the sealing element is completely covered towards the outside.
- the Abbrech consortium encloses the outside of the sealing element and thus closes the outside from the outside, so that no dirt in the form of solid or liquid contaminants can reach the outside.
- the Abbrech consortium is in the initial state advantageously integrally, ie in one piece, connected to the cap.
- the closure cap may in this case be produced, for example, together with the break-off piece as a plastic molded part, for example by means of plastic injection molding.
- the Abbrechmaschine is connected via a predetermined breaking point with the cap body such that the Abbrech collaborate separated along the predetermined breaking point of the cap body, in particular can be canceled to remove the Abbrechfan of the cap body.
- the predetermined breaking point runs around the opening, so that the break-off piece is connected to the cap body along a connecting line around the opening and can be separated from the cap body along this connecting line, in order to release the sealing element and a conveying device to the outside of the cap To be able to apply sealing element.
- an interior or space between the break-off piece and the outside of the sealing element is provided in a sterile manner.
- the outside of the sealing element is already in the state in which the Abbrech Giant is still connected to the cap, sterile. Disinfecting the outside of the sealing element after removing the Abbrech conferencess and before attaching a conveyor, in particular by wiping or blotting, is no longer necessary in this case.
- the closure cap can have, for example, a first connection device for removing a medical fluid and a second connection device for supplying a medical fluid.
- connection devices one of which is designed in particular for the removal of a medical fluid and of which the other in particular for supplying a medical fluid.
- the connection devices can be designed differently in order to make it possible to connect different delivery devices, for example an injection syringe or an infusion set. It is also conceivable and possible, however, to design the connection devices structurally the same and, in particular, to use identical sealing elements on the connection devices.
- each connection device can have a sealing element, wherein the sealing elements of the connection devices are of identical design.
- the same sealing elements are thus used at the connection devices, wherein the holding devices of the same design, for example in the form of provided on the cap recesses for receiving the sealing elements, can be provided. This simplifies the design of the cap as a whole, because the same parts can be used to make the connection devices.
- each sealing element in this variant may have a sealing head which forms the outside, and a sealing body adjoining the sealing head.
- the sealing body can be connected via a peripheral circumferential flange with a collar, over this collar a clamped connection with the cap is made.
- the collar can hedge in an associated recess of the cap and are held there by clamping, so that over the annular collar, the sealing element is connected to the closure cap.
- the sealing element is clamped over a crimping edge.
- an injection cannula or a mandrel of the conveyor can be attached to the outside of the sealing element in order to pierce the sealing element.
- the sealing element is pushed aside, wherein the annular collar remains on the associated holding device of the closure cap and thus the sealing element is held on the closure cap in position. If the conveyor is again removed from the closure cap, then the sealing element closes automatically, so that the opening of the closure cap in turn against a liquid passage, in particular a leakage of liquid out of the container, is sealed.
- the sealing element is in a preferred Embodiment a resealable sealing element.
- the sealing element, in particular the sealing element for connecting a mandrel at least partially or continuously slotted.
- the sealing elements of the connection devices can also be designed differently.
- a sealing element may in this case be designed in particular for applying an injection syringe, while the other sealing element is designed in particular for applying a mandrel of an infusion set or the like.
- the sealing elements can thus be adapted in a special way, for example, with regard to their thickness to be pierced in order to allow a convenient connection of a syringe or an infusion set or the like.
- the sealing element of the first connection device which serves for example for removing a medical fluid by means of an infusion set, can hereby be configured as described above for the first variant and in particular have a sealing head which forms the outside, and a sealing body adjoining the sealing head.
- the sealing body is connected via a peripheral peripheral flange with a collar and held on the annular collar on a first holding means of the cap body.
- the sealing body is to be pierced, for example, by a mandrel of a conveyor, wherein when attaching and piercing the mandrel of the sealing body is pushed aside, the sealing element is held in total on the annular collar but in position on the cap body of the cap.
- the sealing element of the second connection device can have a sealing head, which forms the outside, and a sealing body adjoining the sealing head.
- the sealing body is not fixed to a holding device of the cap body by means of a peripheral annular collar connected via a flange, but is held directly by a peripheral portion on a second holding device of the cap body.
- this second sealing element can be configured in particular for piercing by means of an injection cannula. Because such an injection cannula has a comparatively small cross-section, the puncture of the injection cannula leads to a smaller one Deformation on the sealing element in comparison to the piercing of a mandrel, for example, an infusion set.
- the sealing elements of the different connection devices can be different in this variant, in particular in their thickness, to adapt the connection means the different conveyor.
- the second sealing element which can serve to attach an injection cannula to an injection syringe, can in particular have a greater thickness than the first sealing element, which is adapted, for example, for attaching a mandrel of an infusion set.
- the first sealing element has a central thickness of 2 mm to 8 mm, preferably 3 mm to 6 mm.
- the second sealing element has a central thickness of 2 mm to 8 mm, preferably from 3 mm to 7 mm.
- the sealing elements may have an at least approximately rotationally symmetrical shape.
- the sealing head and the sealing body may each be at least approximately cylindrical, wherein the outer side of the sealing head, which faces outwardly, is convex.
- the underside of the first and / or second sealing element that provides the inside is substantially planar.
- the upper side of the annular collar is lower than the upper side of the sealing head and / or the underside of the annular collar is lower than the underside of the sealing body.
- the first sealing element has an overall diameter of 8 mm to 14 mm, preferably from 10 mm to 12 mm.
- the second sealing element has an overall diameter of 4 mm to 1 1 mm, preferably from 6 mm to 9 mm.
- the sealing head of the first sealing element has a diameter of 4 mm to 10 mm, preferably 6 mm to 8 mm and / or the sealing head of the second sealing element has a diameter of 2 mm to 8 mm, preferably from 3 mm to 6 mm.
- the sealing element is characterized in that it is at least partially convex on an outer side facing away from an inner space of a container.
- the sealing element is curved on its outer side or arcuate.
- the sealing element is a sealing element for connection to a mandrel and / or a cannula.
- a center of the convex outside of the sealing element is 0.1 to 1 mm, preferably 0.3 mm to 0.7 mm, above an outer upper edge of a sealing head of the sealing element.
- a bottle which comprises a closure cap according to the invention described above.
- the bottle may be made, for example, by SBM (stretch blow molding) or BFS (blow fill seal).
- SBM stretch blow molding
- BFS low fill seal
- the bottle and the closure cap can be connected to each other in particular by means of clamping, gluing and / or welding.
- the bottle is filled with an infusion solution.
- FIG. 1A shows a perspective view of a closure cap on a container-shown schematically
- Fig. 1B is a partial sectional view of the closure cap according to Fig. 1A;
- Fig. 1 C is a side view of the arrangement of FIG. 1 B;
- Fig. 2A is a perspective view of the cap, with removed
- FIG. 2B is a partial sectional view of the cap of FIG. 2A; FIG.
- FIG. 2C is a side view of the assembly of FIG. 2B; FIG.
- FIG. 3A shows the view of FIG. 2C, with an attached to a sealing element
- Conveying device in the form of a hypodermic syringe
- 3B shows the view according to FIG. 2C, with a conveying device in the form of an infusion set attached to another sealing element;
- 4A is a perspective view of a first sealing element;
- 4D is a sectional view through the sealing element
- 5A is a perspective view of a second sealing element
- Fig. 5D is a sectional view through the sealing element
- 6A is a perspective view of a second embodiment of a
- FIG. 6B is a partial sectional view of the cap of FIG. 6A; FIG.
- FIG. 6C is a side view of the arrangement of FIG. 6B; FIG.
- FIG. 7A is a perspective view of the closure cap according to FIG. 6A, with removal pieces removed;
- Fig. 7B is a partial sectional view of the arrangement of Fig. 7A.
- Fig. 7C is a side view of the arrangement of FIG. 7B.
- FIG. 1A-1C to 5A-5D show a first embodiment of a closure cap 2, which can be attached to a container 1, in particular in the form of a bottle, for example a plastic bottle or a glass bottle, to the container 1 to the outside to close and provide access to fill or withdraw medical fluid.
- a closure cap 2 can be attached to a container 1, in particular in the form of a bottle, for example a plastic bottle or a glass bottle, to the container 1 to the outside to close and provide access to fill or withdraw medical fluid.
- the cap 2 is attached to a container body 10 of the container 1 and connected in a sealing manner with the container body 10, for example, welded or glued.
- the closure cap 2 has a cap body 20 which has on a top side 21 two attachment devices 3, 4 for connecting different delivery devices 5, 6 (see FIGS. 3A and 3B).
- the connection devices 3, 4 each have a sealing element 31, 41, which is accommodated in a holding device 32, 42 in the form of a positive receptacle on the cap body 20 and is held by clamping on the holding device 32, 42.
- the holding devices 32 and 42 are each formed as a, preferably annular, beaded edge.
- the sealing elements 31, 41 serve to close openings 321, 421 on the upper side 21 of the cap body 20 to the outside, for which purpose in each case a sealing head 310, 410 of the sealing element 31, 41 protrudes into the associated opening 321, 421 and sealingly seals them ,
- the sealing elements 31, 41 are inserted into the openings 321, 421 at first non-bent holding devices 32 and 42.
- the holding devices 32 and 42 then, as shown for example in Figure 1 C, bent.
- the connecting devices 3, 4 are in an initial state, shown in Fig. 1A-1 C, each covered by a Abbrech Division 30, 40 and sealed to the outside, that the openings 321, 421 with the sealing elements 31, 41 disposed therein from the outside not accessible and protected against contamination.
- the interior formed by the Abbrech Gla 30, 40 is sterile.
- a first connection device 3 is used to remove a medical fluid from the container 1.
- another, second connection device 4 serves to supply a medical fluid into the container 1.
- the removal of a medical fluid as shown in Fig. 3B, via a conveyor 6 in the form of an example formed by an infusion set removal device having a mandrel 61 with a comparatively large cross-section and can be attached to the mandrel 61 to the sealing element 31 of the associated connection device 3.
- the supply of a medical liquid takes place via a conveying device 5 in the form of an injection syringe, shown in FIG. 3A, which can be attached to the sealing element 41 of the associated second connecting device 4 with an injection cannula 51 in order to puncture the sealing element 41.
- the associated opening 321 of the attachment device 3 is comparatively large, and accordingly this has in its basic form rotationally symmetrical sealing element 31 has a sealing head 310 with a comparatively large diameter.
- the sealing head 310 of the first sealing element 31 has a diameter of preferably from 5 mm to 9 mm and / or the sealing head 410 of the second sealing element 41 has a diameter of 3 mm to 6 mm.
- the opening 421 of the other, second connection device 4 is smaller, and correspondingly, the sealing head 410 of the second sealing element 41 extending into the opening has a comparatively small diameter.
- FIGS. 4A-4D and 5A-5D Detailed, separate illustrations of the sealing elements 31, 41 are shown in FIGS. 4A-4D and 5A-5D.
- the first sealing element 31 has a sealing head 310 with an outwardly facing, convex outer side 31 1.
- a sealing head 310 At the sealing head 310 includes - back of the outside 31 1 - a sealing body 312, which is connected via a peripheral flange 313 with a likewise circumferentially encircling annular collar 314.
- the sealing element 31 is located in an opening 320 of the holding device 32 and is held by clamping on the holding device 32.
- An underside 315 of the sealing element 31 points into an interior 20 of the closure cap 2 (see, for example, Fig. 3A).
- the underside 31 of the first sealing element 31 is substantially planar here.
- the upper side of the annular collar 314 is lower than the outer or upper side 31 1 of the sealing head 310.
- the underside of the annular collar 314 is lower than the inner or lower side 315 of the first sealing body 31. The annular collar 314 thus extends beyond the underside 315.
- the other, second sealing element 41 also has a rotationally symmetrical shape and consists of a sealing head 410, to the rear of a convex curved outer side 41 1, a cylindrical sealing body 412 connects.
- the sealing element 41 is fixed directly in an opening 420 of the associated, second holding device 42 by a peripheral portion 413 of the sealing element 41 is clamped in the opening 420 of the holding device 42.
- An underside 414 of the sealing element 41 points towards the interior 200 of the closure cap 2.
- the underside 414 of the second sealing element 41 is substantially planar here.
- the different shape in diameter and thickness is due to the fact that when attaching a mandrel 61, as shown in Fig. 3B, the associated, first sealing element 31 is pushed to a much greater extent aside when attaching an injection cannula 51 to the associated, second Sealing element 41.
- the first sealing element 31 can thus be punctured and displaced in a favorable manner when applying a mandrel.
- Both sealing elements 31, 41 close automatically again when the respective associated conveyor 5.6 is in turn removed from the connection device 3.4.
- the sealing element 31, 41 on its outer sides 31 1, 41 1 are convexly curved and also protrude beyond the top 21 of the cap body 20 to the outside, the sealing element 31, 41 can be dabbed or wiped in a favorable manner for the purpose of disinfection, such as this may be prescribed by legal requirements if necessary.
- the shape of the sealing elements 31, 41 on their outer sides 31 1, 41 1 can be ensured that the outer sides 31 1, 41 1 can be achieved by a suitable disinfecting tool, such as a swab or a wipe, in addition due to the convex Curvature is ensured that a disinfecting liquid or other residues after dabbing or wiping does not remain on the outside 31 1, 41 1, but the sealing element 31, 41 can be wiped in a favorable manner.
- the central region of the sealing head 310 preferably has a thickness which is 0.1 to 1 mm greater than the edge region of the sealing head 310.
- the center of the convex region (see FIGS. 4B and 5B) is around 0.1 to 1 mm, preferably by 0.3 mm to 0.7 mm, above the outer edge.
- connection device 3 For attaching a conveyor 5, 6 to an associated connection device 3, 4 is basically the procedure as follows.
- the closure cap 2 connected to the container 1 is present with snap-off pieces 30, 40 arranged fixedly thereon.
- the Abbrech Partnerse 30, 40 are integrally formed with the cap body 20 and over circumferential predetermined breaking points 300, 400 connected to the cap body 20 so that the outer sides 31 1, 41 1 of the sealing elements 31, 41 are covered to the outside.
- a conveyor 5, 6 are attached to an associated connection device 3, 4, then the respective Abbrech Gran 30, 40 is removed from the cap body 20 by a user, the Abbrech Glance 30, 40 between his fingers and engages the cap body 20 along the predetermined breaking point 300, 400 breaks off. In this way, the respective sealing element 31, 41 exposed, so that the conveyor 5, 6 can be attached to the outside 31 1, 41 1 of the sealing element 31, 41 (see Fig. 2A to 2C).
- the sealing element 31, 41 is now pierced, so that a flow connection between a body 50, 60 of the respective conveyor 5, 6 and the interior of the container 1 is created, so that a medical liquid is filled in or out of the container 1 the container 1 can be removed.
- the closure cap 2 may preferably be made of plastic with its cap body 20, for example by means of plastic injection molding.
- the Abbrech Partners 30, 40 of the connecting devices 3, 4 are in this case first formed integrally with the cap body and can be canceled for accessing one of the sealing elements 31, 41 from the cap body 20.
- the sealing elements 31, 41 are made of a relatively soft, elastic material, such as polyisoprene or a thermoplastic elastomer.
- connection devices 3, 4 have identical sealing elements 31, 41, which are arranged in a clamping manner in mutually identical holding devices 32, 42.
- the shape of the sealing elements 31, 41 corresponds to the embodiment shown in FIGS. 4A-4D.
- a connection device 3 serves to remove a medical fluid from a container 1 connected to the closure cap 2, while the other attachment device 4 serves to fill a medical fluid.
- a conveyor 5 in the form of a syringe with an injection cannula or a conveyor with a mandrel can be used.
- FIGS. 6A-6C and FIGS. 7A-7C is identical to the exemplary embodiment described above, so that reference should be made to the above explanations.
- a closure cap can also have only one connection device with one sealing element or more than two connection devices each with a sealing element.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15161249 | 2015-03-27 | ||
PCT/EP2016/056633 WO2016156242A1 (de) | 2015-03-27 | 2016-03-24 | Verschlusskappe für ein behältnis zum aufnehmen einer medizinischen flüssigkeit |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3274266A1 true EP3274266A1 (de) | 2018-01-31 |
EP3274266B1 EP3274266B1 (de) | 2020-04-22 |
Family
ID=52780441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16712842.0A Active EP3274266B1 (de) | 2015-03-27 | 2016-03-24 | Verschlusskappe für ein behältnis zum aufnehmen einer medizinischen flüssigkeit |
Country Status (5)
Country | Link |
---|---|
US (1) | US11351090B2 (de) |
EP (1) | EP3274266B1 (de) |
CN (1) | CN107405256B (de) |
HK (1) | HK1245741A1 (de) |
WO (1) | WO2016156242A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102016012059A1 (de) * | 2016-10-08 | 2018-04-12 | Fresenius Kabi Deutschland Gmbh | Konnektor für ein eine Flüssigkeit enthaltendes medizinisches Packmittel |
KR102639913B1 (ko) | 2017-11-17 | 2024-02-23 | 코스카 패밀리 리미티드 | 유체 전달 매니폴드를 위한 시스템 및 방법 |
DE102020208146A1 (de) * | 2020-06-30 | 2021-12-30 | B. Braun Melsungen Aktiengesellschaft | Kappe für medizinischen Fluidbehälter, Ansatzteil für Kappe, System umfassend Kappe und Ansatzteil, medizinischer Fluidbehälter, System umfassend medizinischen Fluidbehälter und Ansatzteil, Verfahren zum Herstellen eines Fluidbehälters |
CN111840069B (zh) * | 2020-07-10 | 2022-11-15 | 万晶晶 | 生理盐水容器用密封盖及生理盐水容器 |
EP4082600A1 (de) * | 2021-04-30 | 2022-11-02 | B. Braun Melsungen AG | Ventil, verfahren zur herstellung eines ventils, kappe für einen flüssigkeitsbehälter mit einem solchen ventil, flüssigkeitsbehälter mit einer solchen kappe und verfahren zur herstellung einer solchen kappe |
EP4082599A1 (de) * | 2021-04-30 | 2022-11-02 | B. Braun Melsungen AG | Kappe für einen flüssigkeitsbehälter, flüssigkeitsbehälter mit solch einer kappe und verfahren zur herstellung solch einer kappe |
USD992110S1 (en) | 2021-08-10 | 2023-07-11 | Koska Family Limited | Sealed fluid container |
WO2023148317A1 (de) | 2022-02-04 | 2023-08-10 | Fresenius Kabi Deutschland Gmbh | Verschlusskappe für einen medizinischen behälter sowie verfahren zu deren montage |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2230560A1 (en) | 1973-05-22 | 1974-12-20 | Pasteur Lyon Sud Est Inst | Elastic stopper for culture bottle - with screwed capsule for progressive release of fermentation gases |
US5957898A (en) * | 1997-05-20 | 1999-09-28 | Baxter International Inc. | Needleless connector |
DE19858715B4 (de) * | 1998-12-18 | 2004-08-12 | Helvoet Pharma Belgium N.V. | Entnahmevorrichtung zur festen Anordnung auf dem geschlossen ausgebildeten Behälterhals eines Medikamenten-, insbesondere Infusionsbehälters |
RU2379217C2 (ru) * | 2002-09-03 | 2010-01-20 | Медикал Инстилл Текнолоджис, Инк. | Пузырек в сборе для хранения вещества (варианты), устройство в сборе, содержащее пузырек, и способ заполнения пузырька |
CN101596962B (zh) * | 2003-01-28 | 2011-03-23 | 因斯蒂尔医学技术有限公司 | 具有可热封帽的药剂瓶以及灌装该药剂瓶的设备和方法 |
DE10311154A1 (de) * | 2003-03-14 | 2004-09-23 | Helvoet Pharma Belgium N.V. | Für pharmazeutische Verwendung dienende Überkappe mit Verschlussstopfen |
KR20060010822A (ko) * | 2003-05-22 | 2006-02-02 | 오스카 파마슈티칼 팩토리 인코포레이티드 | 밀봉체와 그것을 구비하는 캡 및 의료용 용기 |
DE102004051300C5 (de) * | 2004-10-20 | 2013-01-24 | Fresenius Kabi Deutschland Gmbh | Verschlusskappe für mit medizinischen Flüssigkeiten befüllte Behältnisse |
US7780023B2 (en) | 2006-04-10 | 2010-08-24 | Medical Instill Technologies, Inc. | Ready to drink container with nipple and needle penetrable and laser resealable portion, and related method |
TW200808293A (en) * | 2006-04-25 | 2008-02-16 | Naigai Kasei Co Ltd | A medical cap and a producing method thereof |
DE102007005407A1 (de) | 2007-02-03 | 2008-08-07 | Fresenius Kabi Deutschland Gmbh | Verschlusskappe für ein Behältnis zur Aufnahme von medizinischen Flüssigkeiten und Behältnis zur Aufnahme von medizinischen Flüssigkeiten |
DE102008060864A1 (de) | 2008-12-09 | 2010-06-10 | Fresenius Kabi Deutschland Gmbh | Verschlusskappe für Behältnisse zur Aufnahme von medizinischen Flüssigkeiten und Behältnis zur Aufnahme von medizinischen Flüssigkeiten |
EP2359799A1 (de) * | 2010-02-16 | 2011-08-24 | Fresenius Kabi Deutschland GmbH | Verschlusskappe für ein Behältnis zur Aufnahme von medizinischen Flüssigkeiten und Behältnis |
DE102012021525A1 (de) | 2012-10-31 | 2014-04-30 | Kocher-Plastik Maschinenbau Gmbh | Dichtungsanordnung sowie einer solchen zugeordneter Behälter |
-
2016
- 2016-03-24 CN CN201680018378.1A patent/CN107405256B/zh active Active
- 2016-03-24 EP EP16712842.0A patent/EP3274266B1/de active Active
- 2016-03-24 WO PCT/EP2016/056633 patent/WO2016156242A1/de active Application Filing
- 2016-03-24 US US15/551,414 patent/US11351090B2/en active Active
-
2018
- 2018-04-08 HK HK18104561.1A patent/HK1245741A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1245741A1 (zh) | 2018-08-31 |
EP3274266B1 (de) | 2020-04-22 |
US11351090B2 (en) | 2022-06-07 |
US20180055734A1 (en) | 2018-03-01 |
WO2016156242A1 (de) | 2016-10-06 |
CN107405256A (zh) | 2017-11-28 |
CN107405256B (zh) | 2020-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3274266B1 (de) | Verschlusskappe für ein behältnis zum aufnehmen einer medizinischen flüssigkeit | |
DE68922508T2 (de) | Verfahren zum herstellung einer Kunststoffampulle. | |
EP0235139B1 (de) | Injektionsspritze | |
EP2242698B1 (de) | Verschlusskappe | |
EP2376341B1 (de) | Verschluss für ein medikamentenbehältnis | |
EP0344476A2 (de) | Ampulle | |
WO2014067597A1 (de) | Dichtungsanordnung sowie einer solchen zugeordneter behälter | |
WO2002098748A1 (de) | Verschluss für eine medikamentenflasche sowie verfahren zu dessen herstellung | |
DE102013012809A1 (de) | Kopfstück für einen mit einem Medium befüllbaren Behälter | |
EP1239963A2 (de) | Verschlussvorrichtung für einen unterdruck-probensammelbehälter | |
DE102017000048A1 (de) | Behälter | |
EP3174812B1 (de) | Behälter mit kopfstück, der mit einem medium befüllbar oder befüllt ist | |
EP2847084B1 (de) | Verschlusskappe | |
EP3519315A1 (de) | Verschlusskappe für ein behältnis zum aufnehmen einer medizinischen flüssigkeit | |
DE2844206C2 (de) | Schutzkappe | |
EP2753289B1 (de) | Flüssigkeitsbehälter mit sollbruchstelle | |
EP3294256A1 (de) | Behältnis für eine medizinische flüssigkeit | |
DE2628771C3 (de) | Verschlußkappe für Flaschen mit pharmazeutischem Inhalt | |
DE4425433C1 (de) | Behältnis zur Aufnahme medizinischer Flüssigkeit | |
DE102009033908A1 (de) | Für die Entnahme von medizinischen Flüssigkeiten aus Verpackungen geeignete Vorrichtung und damit ausgestattete Verpackung | |
DE102017002401A1 (de) | Kunststoff-Behältererzeugnis | |
EP0617949A1 (de) | Infusionsflasche | |
DE9317644U1 (de) | Verschlußkappe | |
EP0597220A2 (de) | Medizinisches Übertragungsgerät | |
AT525541A4 (de) | Aufnahmeeinrichtung mit Septum und Verfahren zu dessen Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20171011 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1245741 Country of ref document: HK |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20191204 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 502016009650 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1259795 Country of ref document: AT Kind code of ref document: T Effective date: 20200515 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200723 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200824 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200722 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200822 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200722 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 502016009650 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20210125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20210331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210324 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210331 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210331 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210324 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 1259795 Country of ref document: AT Kind code of ref document: T Effective date: 20210324 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210331 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210324 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20160324 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240129 Year of fee payment: 9 Ref country code: GB Payment date: 20240129 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240129 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200422 |